United States · FDA National Drug Code directory
hydroxyzine pamoate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68788-7767_c3b04bc3-c236-4ada-ad96-03e0e0327c9d
- Product NDC
- 68788-7767
- Form
- CAPSULE
- Composition / generic term
- hydroxyzine pamoate
- Labeler
- Preferred Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200803
- Source listing expiry
- 20261231
Source-listed ingredients
- HYDROXYZINE PAMOATE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 CONTAINER (68788-7767-1) · 68788-7767-1
- 30 CAPSULE in 1 CONTAINER (68788-7767-3) · 68788-7767-3
- 15 CAPSULE in 1 CONTAINER (68788-7767-5) · 68788-7767-5
- 60 CAPSULE in 1 CONTAINER (68788-7767-6) · 68788-7767-6
- 90 CAPSULE in 1 CONTAINER (68788-7767-9) · 68788-7767-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →